TY - JOUR
T1 - Characterization of an Adapted Murine Model of Intrauterine Inflammation–Induced Preterm Birth
AU - Zierden, Hannah C.
AU - Ortiz Ortiz, Jairo I.
AU - Dimitrion, Peter
AU - Laney, Victoria
AU - Bensouda, Sabrine
AU - Anders, Nicole M.
AU - Scardina, Morgan
AU - Hoang, Thuy
AU - Ronnett, Brigitte M.
AU - Hanes, Justin
AU - Burd, Irina
AU - Mahendroo, Mala
AU - Ensign, Laura M.
N1 - Funding Information:
Supported by the Burroughs Wellcome Preterm Birth Initiative grant 1015020 (L.E.) and a National Science Foundation Graduate Research Fellowship Program Fellowship DGE-1746891 (H.Z.). Wilmer Microscopy and Imaging Core Facility (The Wilmer Eye Institute) is supported by NIH grant P30EY001765. Plasma progesterone analysis was supported by the Analytical Pharmacology Core of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (NIH grants P30CA006973 and UL1TR001079 and the Shared Instrument grant S10RR026824), National Center for Advancing Translational Sciences/NIH grant UL1TR001079, and the NIH Roadmap for Medical Research.
Publisher Copyright:
© 2020 American Society for Investigative Pathology
PY - 2020/2
Y1 - 2020/2
N2 - Preterm birth (PTB) affects nearly 15 million infants each year. Of these PTBs, >25% are a result of inflammation or infection. Animal models have improved our understanding of the mechanisms leading to PTB. Prior work has described induction of intrauterine inflammation in mice with a single injection of lipopolysaccharide (LPS). Herein, we have improved the reproducibility and potency of LPS in the model using two injections distal to the cervix. An in vivo imaging system revealed more uniform distribution of Evans Blue Dye using a double distal injection (DDI) approach compared with a single proximal injection (SPI). Endotoxin concentrations in vaginal lavage fluid from SPI dams were significantly higher than from DDI dams. At equivalent LPS doses, DDI consistently induced more PTB than SPI, and DDI showed a linear dose-response, whereas SPI did not. Gene expression in myometrial tissue revealed increased levels of inflammatory markers in dams that received LPS DDI compared with LPS SPI. The SPI group showed more significant overexpression in cervical remodeling genes, likely due to the leakage of LPS from the uterine horns through the cervix. The more reliable PTB induction and uniform uterine exposure provided by this new model will be useful for further studying fetal outcomes and potential therapeutics for the prevention of inflammation-induced PTB.
AB - Preterm birth (PTB) affects nearly 15 million infants each year. Of these PTBs, >25% are a result of inflammation or infection. Animal models have improved our understanding of the mechanisms leading to PTB. Prior work has described induction of intrauterine inflammation in mice with a single injection of lipopolysaccharide (LPS). Herein, we have improved the reproducibility and potency of LPS in the model using two injections distal to the cervix. An in vivo imaging system revealed more uniform distribution of Evans Blue Dye using a double distal injection (DDI) approach compared with a single proximal injection (SPI). Endotoxin concentrations in vaginal lavage fluid from SPI dams were significantly higher than from DDI dams. At equivalent LPS doses, DDI consistently induced more PTB than SPI, and DDI showed a linear dose-response, whereas SPI did not. Gene expression in myometrial tissue revealed increased levels of inflammatory markers in dams that received LPS DDI compared with LPS SPI. The SPI group showed more significant overexpression in cervical remodeling genes, likely due to the leakage of LPS from the uterine horns through the cervix. The more reliable PTB induction and uniform uterine exposure provided by this new model will be useful for further studying fetal outcomes and potential therapeutics for the prevention of inflammation-induced PTB.
UR - http://www.scopus.com/inward/record.url?scp=85077926907&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85077926907&partnerID=8YFLogxK
U2 - 10.1016/j.ajpath.2019.10.013
DO - 10.1016/j.ajpath.2019.10.013
M3 - Article
C2 - 31837289
AN - SCOPUS:85077926907
SN - 0002-9440
VL - 190
SP - 295
EP - 305
JO - American Journal of Pathology
JF - American Journal of Pathology
IS - 2
ER -